Literature DB >> 23625813

Glomerular filtration rate equations overestimate creatinine clearance in older individuals enrolled in the Baltimore Longitudinal Study on Aging: impact on renal drug dosing.

Thomas C Dowling1, En-Shih Wang, Luigi Ferrucci, John D Sorkin.   

Abstract

OBJECTIVES: To evaluate the performance of kidney function estimation equations and to determine the frequency of drug dose discordance in an older population.
DESIGN: Cross-sectional analysis of data from community-dwelling volunteers randomly selected from the Baltimore Longitudinal Study of Aging from January 1, 2005, to December 31, 2010.
SUBJECTS: A total of 269 men and women with a mean ± SD age of 81 ± 6 years, mean serum creatinine concentration (Scr ) of 1.1 ± 0.4 mg/dl, and mean 24-hour measured creatinine clearance (mClcr ) of 53 ± 13 ml/minute.
MEASUREMENTS AND MAIN RESULTS: Kidney function was estimated by using the following equations: Cockcroft-Gault (CG), Modification of Diet in Renal Disease (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). The performance of each equation was assessed by measuring bias and precision relative to mClcr . Dose calculation errors (discordance) were determined for 10 drugs requiring renal dosage adjustments to avoid toxicity when compared with the dosages approved by the Food and Drug Administration. The CG equation was the least biased estimate of mClcr . The MDRD and CKD-EPI equations were significantly positively biased compared with CG (mean ± SD 34 ± 20% and 22 ± 15%, respectively, p<0.001) and mClcr (29 ± 47% and 18 ± 40%, respectively, p<0.001). Rounding low Scr values (less than 1.0 mg/dl) up to an arbitrary value of 1.0 mg/dl resulted in CG values (44 ± 10 ml/minute) that were significantly lower than mClcr (56 ± 12 ml/minute, p<0.001) and CG (56 ± 15 ml/minute, p<0.001). The MDRD and CKD-EPI equations had median dose discordance rates of 28.6% and 22.9%, respectively.
CONCLUSION: The MDRD and CKD-EPI equations significantly overestimated creatinine clearance (mClcr and CG) in elderly individuals. This leads to dose calculation errors for many drugs, particularly in individuals with severe renal impairment. Thus equations estimating glomerular filtration rate should not be substituted in place of the CG equation in older adults for the purpose of renal dosage adjustments. In addition, the common practice of rounding or replacing low Scr values with an arbitrary value of 1.0 mg/dl for use in the CG equation should be avoided. Additional studies that evaluate alternative eGFR equations in the older populations that incorporate pharmacokinetic and pharmacodynamic outcomes measures are needed.
© 2013 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  BLSA; GFR; creatinine clearance; drug safety; geriatrics; glomerular filtration rate

Mesh:

Substances:

Year:  2013        PMID: 23625813      PMCID: PMC3732548          DOI: 10.1002/phar.1282

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  42 in total

1.  Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations.

Authors:  Yuen-Ting Diana Kwong; Lesley A Stevens; Elizabeth Selvin; Yaping Lucy Zhang; Tom Greene; Frederick Van Lente; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2010-07       Impact factor: 8.860

2.  Estimated GFR vs creatinine clearance for drug dosing.

Authors:  Thomas C Dowling; Gary R Matzke; John E Murphy
Journal:  Am J Kidney Dis       Date:  2009-11       Impact factor: 8.860

3.  Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.

Authors:  Joachim Stangier; Karin Rathgen; Hildegard Stähle; Dago Mazur
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

4.  Dofetilide dose calculation errors in elderly associated with use of the modification of diet in renal disease equation.

Authors:  Tina H Denetclaw; Nancy Oshima; Thomas C Dowling
Journal:  Ann Pharmacother       Date:  2011-06-28       Impact factor: 3.154

5.  Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches.

Authors:  Thomas C Dowling; Gary R Matzke; John E Murphy; Gilbert J Burckart
Journal:  Pharmacotherapy       Date:  2010-08       Impact factor: 4.705

6.  Potentially inappropriate prescribing of primarily renally cleared medications for older veterans affairs nursing home patients.

Authors:  Joseph T Hanlon; Xiaoqiang Wang; Steven M Handler; Steven Weisbord; Mary Jo Pugh; Todd Semla; Roslyn A Stone; Sherrie L Aspinall
Journal:  J Am Med Dir Assoc       Date:  2010-10-02       Impact factor: 4.669

7.  The use of dabigatran in elderly patients.

Authors:  Matthieu Legrand; Joaquim Mateo; Alice Aribaud; Sixtine Ginisty; Pirayeh Eftekhari; Patrice Tran Ba Huy; Ludovic Drouet; Didier Payen
Journal:  Arch Intern Med       Date:  2011-07-25

8.  Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Authors:  Lars Wallentin; Salim Yusuf; Michael D Ezekowitz; Marco Alings; Marcus Flather; Maria Grazia Franzosi; Prem Pais; Antonio Dans; John Eikelboom; Jonas Oldgren; Janice Pogue; Paul A Reilly; Sean Yang; Stuart J Connolly
Journal:  Lancet       Date:  2010-09-18       Impact factor: 79.321

9.  Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.

Authors:  R L Lalonde; J A Wagner
Journal:  Clin Pharmacol Ther       Date:  2009-09-23       Impact factor: 6.875

10.  Single-Dose pharmacokinetics of sustained-release fampridine (Fampridine-SR) in healthy volunteers and adults with renal impairment.

Authors:  William Smith; Suzanne Swan; Thomas Marbury; Herbert Henney
Journal:  J Clin Pharmacol       Date:  2009-12-04       Impact factor: 3.126

View more
  44 in total

1.  Discrepancy Between Equations Estimating Kidney Function in Geriatric Care: A Study of Implications for Drug Prescription.

Authors:  Florent Guerville; Claire Roubaud-Baudron; Sophie Duc; Nathalie Salles; Muriel Rainfray; Isabelle Bourdel-Marchasson
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

2.  Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.

Authors:  Teresa M Salgado; Blanca Arguello; Fernando Martinez-Martinez; Shalom I Benrimoj; Fernando Fernandez-Llimos
Journal:  Eur J Clin Pharmacol       Date:  2013-07-25       Impact factor: 2.953

Review 3.  Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

4.  The relationship between intra-parenchymal renal resistive index variation and renal functional reserve in healthy subjects.

Authors:  Sara Samoni; Gianluca Villa; Silvia De Rosa; Mauro Neri; Lorenzo Tofani; Faeq Husain-Syed; Massimo De Cal; Federico Nalesso; Mario Meola; Claudio Ronco
Journal:  J Nephrol       Date:  2020-06-29       Impact factor: 3.902

5.  Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants?

Authors:  Nicoletta Riva; Walter Ageno; Alex Gatt
Journal:  Intern Emerg Med       Date:  2018-05-24       Impact factor: 3.397

6.  Thromboprophylaxis with fondaparinux in high-risk postoperative patients with renal insufficiency.

Authors:  Willie Hester; Caitlyn Fry; Daniel Gonzalez; Michael Cohen-Wolkowiez; Brant A Inman; Thomas L Ortel
Journal:  Thromb Res       Date:  2013-11-23       Impact factor: 3.944

7.  Chronic kidney disease in the elderly: evaluation and management.

Authors:  Mary Mallappallil; Eli A Friedman; Barbara G Delano; Samy I McFarlane; Moro O Salifu
Journal:  Clin Pract (Lond)       Date:  2014

8.  Age-dependent error in creatinine clearance estimated by Cockcroft-Gault equation for the elderly patients in a Japanese hospital: a cross-sectional study.

Authors:  Mitsuhiro Matsuo; Fuminori Yamagishi
Journal:  J Anesth       Date:  2019-01-02       Impact factor: 2.078

Review 9.  Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.

Authors:  Mauro Molteni; Mario Bo; Giovanni Di Minno; Giuseppe Di Pasquale; Simonetta Genovesi; Danilo Toni; Paolo Verdecchia
Journal:  Intern Emerg Med       Date:  2017-04-24       Impact factor: 3.397

Review 10.  The Role of Deprescribing in Older Adults with Chronic Kidney Disease.

Authors:  Laura K Triantafylidis; Chelsea E Hawley; Laura P Perry; Julie M Paik
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.